Addition Of NeoRecormon May Make Vidaza Treatment More Tolerable …

Addition Of NeoRecormon May Make Vidaza Treatment More Tolerable …

Results of a French Phase 2 clinical trial indicate that the addition of the … (ESAs) are used in myelodysplastic syndromes (MDS) patients to prevent low …
See all stories on this topic »

Treating Lower Risk MDS in 2012: Applying the Most Current …

Treating Lower Risk MDS in 2012: Applying the Most Current Clinical Research to Patient Care. Presentation Link: View this webcast on our Online Learning …
See all stories on this topic »

**********************
MORE USEFUL INFORMATION....
The LINKS below are from high authority and related sites.
You might also find them useful. Thanks for visiting !


Addition Of NeoRecormon May Make Vidaza Treatment More Tolerable ...
Addition Of NeoRecormon May Make Vidaza Treatment More Tolerable ...
Clinical Center News
NIMH » Science News about Clinical Research and Trials